Defence Therapeutics Inc. (DTC) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.54x
Defence Therapeutics Inc. (DTC) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of €-1.40 Million could theoretically repay -1% of its total liabilities (€2.59 Million) in one year. See Defence Therapeutics Inc. (DTC) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.54x
Operating CF / Total Liabilities
Operating Cash Flow
€-1.40 Million
EUR
Total Liabilities
€2.59 Million
EUR
Data as of
Dec 2025
Most recent filing
Defence Therapeutics Inc. Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Defence Therapeutics Inc. across 5 annual periods. For the full cash flow conversion analysis, see DTC cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Defence Therapeutics Inc. (2020–2024)
Year-by-year debt coverage analysis for Defence Therapeutics Inc..
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.06x | €-4.29 Million | €4.06 Million | ▲ +72.9% |
| 2023 | -3.89x | €-7.66 Million | €1.97 Million | ▲ +28.7% |
| 2022 | -5.46x | €-6.04 Million | €1.11 Million | ▲ +70.9% |
| 2021 | -18.73x | €-2.29 Million | €122.26K | ▼ -581.7% |
| 2020 | -2.75x | €-132.83K | €48.35K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.